These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
655 related items for PubMed ID: 16382303
1. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ. Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303 [Abstract] [Full Text] [Related]
2. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G. Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [Abstract] [Full Text] [Related]
3. Defect in glucokinase translocation in Zucker diabetic fatty rats. Fujimoto Y, Donahue EP, Shiota M. Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155 [Abstract] [Full Text] [Related]
4. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Wheatley CM, Rattigan S, Richards SM, Barrett EJ, Clark MG. Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E804-9. PubMed ID: 15213062 [Abstract] [Full Text] [Related]
5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM. Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047 [Abstract] [Full Text] [Related]
6. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure. Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A. Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242 [Abstract] [Full Text] [Related]
7. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD. Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738 [Abstract] [Full Text] [Related]
8. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats. Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH. J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098 [Abstract] [Full Text] [Related]
9. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats. Beha A, Juretschke HP, Kuhlmann J, Neumann-Haefelin C, Belz U, Gerl M, Kramer W, Roden M, Herling AW. Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389 [Abstract] [Full Text] [Related]
10. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats. Berthiaume N, Carlson CJ, Rondinone CM, Zinker BA. Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642 [Abstract] [Full Text] [Related]
11. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats. Freedman MR, Stern JS, Reaven GM, Mondon CE. Horm Metab Res; 1986 May; 18(5):296-8. PubMed ID: 3522389 [Abstract] [Full Text] [Related]
12. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P. J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504 [Abstract] [Full Text] [Related]